[1]刘博深,王轶,郭林民,等.GlcNAc经O-糖基化依赖性途径抑制大鼠阴茎海绵体平滑肌细胞中MAPKs通路[J].第三军医大学学报,2019,41(03):206-212.
 LIU Boshen,WANG Yi,GUO Linmin,et al.GlcNAc inhibits MAPKs pathway in rat corpus cavernosum smooth muscle cells via Oglycosylation-dependent pathway[J].J Third Mil Med Univ,2019,41(03):206-212.
点击复制

GlcNAc经O-糖基化依赖性途径抑制大鼠阴茎海绵体平滑肌细胞中MAPKs通路(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第03期
页码:
206-212
栏目:
基础医学
出版日期:
2019-02-15

文章信息/Info

Title:
GlcNAc inhibits MAPKs pathway in rat corpus cavernosum smooth muscle cells via Oglycosylation-dependent pathway
作者:
刘博深王轶郭林民孙中义
陆军军医大学(第三军医大学)第三附属医院(野战外科研究所)泌尿外科
Author(s):
LIU Boshen WANG Yi GUO Linmin SUN Zhongyi

Department of Urology, Institute of Surgery Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China

关键词:
海绵体平滑肌细胞GlcNAcO-糖基化MAPKs
Keywords:
cavernous smooth muscle cells &beta-N-acetylglucosamine O-glycosylation mitogen-activated protein kinases
分类号:
R-33; R322.64; R329.26
文献标志码:
A
摘要:

目的 探讨β-N-乙酰氨基葡萄糖(β-N-acetylglucosamine,GlcNAc)对大鼠阴茎海绵体平滑肌细胞促分裂原活化蛋白激酶(mitogen-activated protein kinases,MAPKs)通路的影响。方法 分离健康成年大鼠阴茎组织,高糖培养基诱导阴茎海绵体平滑肌细胞(cavernous smooth muscle cells,CSMC)分离生长,免疫荧光、免疫组化鉴定CSMC,GlcNAc处理CSMC 12 h,分别于0、10 min、1、2、4、8、12 h收集细胞裂解液,O-(连接)N-乙酰葡糖胺转移酶(O-N-acetylglucosamine transferase,OGT)抑制剂Alloxan、O-(连接)N-乙酰葡糖胺水解酶(O-GlcNAcase,OGA)抑制剂Thiamet G及GlcNAc处理CSMC 72 h,Western blot检测蛋白总糖基化水平及MAPKs通路相关蛋白在12、72 h的磷酸化水平。结果 成功分离培养大鼠CSMC,GlcNAc显著提升了CSMC细胞 O-糖基化水平(P<0.05)。处理细胞后12 h,GlcNAc显著抑制大鼠CSMC的ERK1/2、JNK1/2/3和p38的蛋白磷酸化水平(P<0.05),处理细胞后72 h,GlcNAc显著抑制了大鼠CSMC的ERK1/2和p38蛋白磷酸化水平(P<0.05),但不影响其总蛋白的表达水平(P>0.05),且与Thiamet G的作用相同。另外,GlcNAc与Thiamet G能协同抑制ERK1/2、JNK1/2/3和p38的蛋白磷酸化水平(P<0.05)。结论GlcNAc经O-糖基化依赖性途径抑制阴茎海绵体平滑肌细胞中MAPKs通路。

Abstract:

Objective To investigate the effect of β-N-acetylglucosamine (GlcNAc) on the mitogen-activated protein kinases (MAPKs) pathway in rat penile cavernosum smooth muscle cells. Methods After penile tissue was collected from healthy adult rats, cavernous smooth muscle cells (CSMC) were isolated and cultured under high glucose medium. Immunofluorescence (IF) assay and immunocytochemical (ICC) assay were used to identify CSMC. Then the cells were treated with GlcNAc for 12 h, the cell lysate was collected at 0, 10 min, and 1, 2, 4, 8 and 12 h. Western blotting was employed to detect the total glycosylation level of protein and phosphorylation of MAPKs pathway-associated proteins after the cells were treated with O-N-acetylglucosamine transferase (OGT) inhibitor, Alloxan, O-GlcNAcase (OGA) inhibitor, Thiamet G, and GlcNAc. Results The rat CMSC were successfully isolated. Compared with the control cells, GlcNAc treatment significantly increased the O-glycosylation level of CSMC (P<0.05). At 12 h, GlcNAc significantly inhibited ERK1/2,JNK1/2/3 and p38 (P<0.05),while at 72 h, GlcNAc significantly inhibited the phosphorylation of ERK1/2 and p38 protein in rat CSMC (P<0.05), but did not affect the levels of total proteins (P>0.05), which was the same effect of Thiamet G. In addition, GlcNAc and Thiamet G synergistically inhibited the phosphorylation levels of ERK1/2, JNK1/2/3 and p38 (P<0.05). Conclusion GlcNAc inhibits MAPKs pathway in CSMC via O-glycosylation-dependent pathway.

参考文献/References:

[1]SHAMLOUL R, GHANEM H. Erectile dysfunction[J]. Lancet, 2013, 381(9861): 153-165. DOI: 10.1016/S0140-6736(12)60520-0.
[2]WINGARD C J, MOUKDAR F, PRASAD R Y, et al. Reversal of voltage-dependent erectile responses in the Zucker obesediabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling[J]. J Sex Med, 2009, 6 (Suppl 3):269-278. DOI: 10.1111/j.1743-6109.2008.01184.x.
[3]SNCHEZ A, MARTNEZ P, MUOZ M, et al. Endothelin1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors[J]. Br J Pharmacol, 2014, 171(24): 5682-5695. DOI: 10.1111/bph.12870.
[4]JANG H, BAE W J, KIM S J, et al. The herbal formula KH-204 is protective against erectile dysfunction by minimizing oxidative stress and improving lipid profiles in a rat model of erectile dysfunction induced by hypercholesterolaemia[J]. BMC Complement Altern Med, 2017, 17(1): 129. DOI: 10.1186/s12906-017-1588-4.
[5]MUSICKI B, KRAMER M F, BECKER R E, et al. Inacti-vation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction[J]. Proc Natl Acad Sci U S A, 2005, 102(33): 11870-11875. DOI: 10.1073/pnas.0502488102.
[6]SLAWSON C, COPELAND R J, HART G W. OGlcNAc signaling: a metabolic link between diabetes and cancer?[J]. Trends Biochem Sci, 2010, 35(10): 547-555. DOI: 10.1016/j.tibs.2010.04.005.
[7]PETI W, PAGE R. Molecular basis of MAP kinase regulation[J]. Protein Sci, 2013, 22(12): 1698-1710. DOI: 10.1002/pro.2374.
[8]MUNIZ J J, LEITE L N, LACCHINI R, et al. Dysregulated mitogen-activated protein kinase and matrix metalloproteinase in ethanol-induced cavernosal dysfunction[J]. Can J Physiol Pharmacol, 2018, 96(3): 266-274. DOI: 10.1139/cjpp-2017-0082.
[9]XU Y, GUAN R, LEI H, et al. Implications for differentiation of endogenous stem cells: therapeutic effect from icariside II on a rat model of postprostatectomy erectile dysfunction[J]. Stem Cells Dev, 2015, 24(6): 747-755. DOI: 10.1089/scd.2014.0380.
[10]MATSUI H, SOPKO N A, HANNAN J L, et al. Pathophysiology of erectile dysfunction[J]. Curr Drug Targets, 2015, 16(5): 411-419. DOI: 10.2174/13894501160515050 4114041.
[11]SHEN Y, ZHU X, YANG X, et al. Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation[J]. J Nat Med, 2014, 68(3): 623-629. DOI: 10.1007/s11418-014-0825-0.
[12]LIMA V V, LOBATO N S, FILGUEIRA F P, et al. Vascular O-GlcNAcylation augments reactivity to constrictor stimuli by prolonging phosphorylated levels of the myosin light chain[J]. Braz J Med Biol Res, 2014, 47(10): 826-833. DOI: 10.1590/1414-431X20144001.
[13]DASSANAYAKA S, JONES S P. O-GlcNAc and the cardiovascular system[J]. Pharmacol Ther, 2014, 142(1): 62-71. DOI: 10.1016/j.pharmthera.2013.11.005.
[14]ZEIDAN Q, HART G W. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways[J]. J Cell Sci, 2010, 123(Pt 1): 13-22. DOI: 10.1242/jcs.053678.
[15]JOHNSON G L, DOHLMAN H G, GRAVES L M. MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression[J]. Curr Opin Chem Biol, 2005, 9(3): 325-331. DOI: 10.1016/j.cbpa.2005.04.004.
[16]NIKOLAIENKO O, ERIKSEN M S, PATIL S, et al. Stimulus-evoked ERK-dependent phosphorylation of activity-regulated cytoskeleton-associated protein (Arc) regulates its neuronal subcellular localization[J]. Neuroscience, 2017, 360: 68-80. DOI: 10.1016/j.neuroscience.2017.07.026.
[17]HOTAMISLIGIL G S, DAVIS R J. Cell signaling and stress responses[J]. Cold Spring Harb Perspect Biol, 2016, 8(10): a006072. DOI: 10.1101/cshperspect.a006072.
[18]GOLDBERG H, WHITESIDE C, FANTUS I G. O-linked beta-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells[J]. Am J Physiol Endocrinol Metab, 2011, 301(4): E713-E726. DOI: 10.1152/ajpendo.00108.2011.
[19]KNEASS Z T, MARCHASE R B. Protein OGlcNAc modulates motility-associated signaling intermediates in neutrophils[J]. J Biol Chem, 2005, 280(15): 14579-14585. DOI: 10.1074/jbc.M414066200.
[20]NUNES K P, TOQUE H A, CALDWELL R B, et al. Extracellular signal-regulated kinase (ERK) inhibition decreases arginase activity and improves corpora cavernosal relaxation in streptozotocin (STZ)induced diabetic mice[J]. J Sex Med, 2011, 8(12): 3335-3344. DOI: 10.1111/j.1743-6109.2011.02499.x.

相似文献/References:

[1]裴轶劲,吴小兰,毛方圆,等.N-乙酰氨基葡萄糖对应激小鼠巨噬细胞吞噬功能的调节作用[J].第三军医大学学报,2009,31(19):1869.
 PEI Yi-jin,WU Xiao-lan,MAO Fang-yuan,et al.Regulation of N-Acetyl-D-glucosamine on macrophages function of stressed mice[J].J Third Mil Med Univ,2009,31(03):1869.

更新日期/Last Update: 2019-02-14